Connect with us
PharmaMar wanted to highlight the growth in royalty income, which has increased by 8% compared to the same period of the previous year, reaching a total...
Pharma Mar has decided to liquidate its diagnostic subsidiary Genomics, as part of their strategy to focus on their core activity of drug development and marketing....
According to regulations, an accelerated authorization requires a confirmatory trial, so Pharma Mar announced in December 2021 the start of a confirmatory Phase III clinical trial,...